 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 34
Date: July 30, 2024
Clinical trials with human volunteers are at the very heart of our efforts to develop better therapies. It is all very interesting to read about cell line studies in the lab, or even mouse studies, but the rubber meets the road only when the concepts are tested in real live patients. Patients who volunteer for early stage clinical trials are the real heroes of the medical revolution. Win, lose or draw, their participation in well thought out and well conducted (and promptly reported!!) clinical trials adds to our understanding.
The most recent article on our website, Rituxan plus Campath, discusses a recent article from M. D. Anderson, reporting the results of their Campath + Rituxan clinical trial in late stage CLL patients. There was good reason to hope for synergy between the two monoclonal antibodies: the sum of the two being more than just additive. While this was a non-randomized and single arm study, the results of this important trial are pretty clear, and should provide guidance for researchers and patients alike. If you are considering participating in a similar clinical trial, this article and the references we used in it are very worth reading.
Be well,
Chaya
_____
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
